0000939767-20-000151.txt : 20201113 0000939767-20-000151.hdr.sgml : 20201113 20201113201843 ACCESSION NUMBER: 0000939767-20-000151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201110 FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WYSZOMIERSKI JACK L CENTRAL INDEX KEY: 0001023225 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 201313292 MAIL ADDRESS: STREET 1: SCHERING PLOUGH CORP STREET 2: ONE GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940-1000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_160531670904103.xml FORM 4 X0306 4 2020-11-10 0 0000939767 EXELIXIS, INC. EXEL 0001023225 WYSZOMIERSKI JACK L C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 0 0 0 Common Stock 2020-11-10 4 M 0 62403 5.82 A 231809 D Common Stock 2020-11-10 4 S 0 34000 20.61 D 197809 D Option (right to buy) 5.82 2020-11-10 4 M 0 62403 0 D 2013-12-06 2020-12-05 Common Stock 62403.0 0 D Includes 7,728 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.60 to $20.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. The option, representing the right to purchase a total of 62,403 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-11-13